Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Latest News about Jason Gerberry
Recent news which mentions Jason Gerberry
Xenon Pharmaceuticals May Have A Blockbuster Drug In Store, BofA Says
August 29, 2022
Tickers
XENE
Tags
Jason Gerberry
XENE
Benzinga
From
Benzinga
Why This Teva Pharmaceuticals Analyst Is Turning Bullish 'The Most Room To Re-Rate'
August 05, 2022
Tickers
TEVA
Tags
Price Target
Analyst Ratings
Market News
From
Benzinga
Axsome Therapeutics Rallies 40% On FDA Product Label Proposal, But Analyst Remains Skeptical
June 27, 2022
Tickers
AXSM
Tags
Jason Gerberry
FDA
Benzinga
From
Benzinga
BofA Upgrades Teva Pharmaceutical On Possible Opioid Deal
May 17, 2022
Tickers
TEVA
Tags
Benzinga
Biotech
Pharmaceutical
From
Benzinga
BofA Initiates Arcellx With Buy On Its Novel Therapy Approach
March 01, 2022
Tickers
ACLX
Tags
Jason Gerberry
Benzinga
Small Cap
From
Benzinga
BofA Downgrades Ionis After Vupanorsen Setback: Are There Upcoming Catalysts That Can Help The Stock?
February 01, 2022
Tickers
IONS
Tags
BofA Securities
Analyst Ratings
IONS
From
Benzinga
BofA Downgrades Alkermes After Stock Rally: 'We Don't See A Favorable Catalyst Pathway'
September 02, 2021
Tickers
ALKS
Tags
Benzinga
ALKS
Downgrades
From
Benzinga
FibroGen Analyst Removes Roxadustat Sales From Model After AdCom Snub
July 16, 2021
Tickers
FGEN
Tags
Downgrades
FGEN
Benzinga
From
Benzinga
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.